Form 4: Hims & Hers Health CEO Andrew Dudum Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Hims & Hers Health CEO Andrew Dudum sold shares of Class A Common Stock on June 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Andrew Dudum, CEO of Hims & Hers Health, Inc., sold shares of Class A Common Stock on June 20, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on November 29, 2023.
- Dudum sold 18,314 shares at an average price of $22.3457, 26,741 shares at an average price of $23.3661, and 700 shares at an average price of $24.3075.
- Following these transactions, Dudum directly owns 60,943 shares.
- Dudum also indirectly owns shares through various trusts, including AD 2022 GRAT 3, Andrew Dudum 2015 Trust, AD 2021 GRAT, Dudum Family Community Property Trust, AD 2023 GRAT, AD 2022 GRAT 2, Richard M. Dudum Irrevocable 1 U/A, and Dudum Family Heritage Trust UAD.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-arranged trading plan, which is a common practice.
Industry Context
Insider sales are a common occurrence, and the use of a 10b5-1 trading plan allows insiders to sell shares over a period of time while avoiding concerns about trading on non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under a pre-arranged plan are generally viewed as less informative than discretionary trades.
Comparison to Industry Standards
- Comparing Dudum's transactions to other CEOs in the telehealth industry is difficult without specific data on their trading activity.
- However, it's common for CEOs to utilize 10b5-1 plans for managing their personal finances.
- The size of the transactions is relatively small compared to the overall market capitalization of Hims & Hers Health, Inc.
Stakeholder Impact
- The stock sale could have a minor negative impact on shareholder sentiment, although sales under 10b5-1 plans are generally viewed as less significant.
- The impact on other stakeholders (employees, customers, suppliers, creditors) is likely to be minimal.
Key Dates
| Date | Description |
|---|---|
| 10/15/1997 | Date of Richard M. Dudum Irrevocable 1 U/A |
| 07/02/2015 | Date of Andrew Dudum 2015 Trust |
| 11/01/2021 | Date of AD 2021 GRAT and AD 2021 GRAT 2 |
| 08/10/2021 | Date of Dudum Family Heritage Trust UAD |
| 09/07/2022 | Date of AD 2022 GRAT 2 |
| 11/28/2022 | Date of AD 2022 GRAT 3 |
| 09/05/2023 | Date of AD 2023 GRAT |
| 11/29/2023 | Date the Rule 10b5-1 trading plan was adopted |
| 06/20/2024 | Date of the stock sale transactions |
| 06/21/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.